Skip to Main Content

Author Details

David S Schrump
Center for Cancer Research, National Cancer Institute
1988
184
54
PMIDPaper TitleJournal TitlePublished Year
36456359Current status of National Institutes of Health funding for thoracic surgeons in the United States: Beacon of hope or candle in the wind?J Thorac Cardiovasc Surg2024
36456359Current status of National Institutes of Health funding for thoracic surgeons in the United States: Beacon of hope or candle in the wind?J Thorac Cardiovasc Surg2024
36378541BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation.Mol Cancer Res2023
36378541BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation.Mol Cancer Res2023
37608989A Unique Gene Signature Predicting Recurrence Free Survival in Stage IA Lung Adenocarcinoma.J Thorac Cardiovasc Surg2023
37597186Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy.Cell Rep2023
37974213Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy.J Exp Clin Cancer Res2023
36713582Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile.Front Oncol2023
36883564mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer.JCI Insight2023
36754859CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma.J Pathol Clin Res2023
36870293Cigarette Smoke Enhances the Malignant Phenotype of Esophageal Adenocarcinoma Cells by Disrupting a Repressive Regulatory Interaction Between miR-145 and LOXL2.Lab Invest2023
37597186Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy.Cell Rep2023
37608989A Unique Gene Signature Predicting Recurrence Free Survival in Stage IA Lung Adenocarcinoma.J Thorac Cardiovasc Surg2023
37974213Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy.J Exp Clin Cancer Res2023
36883564mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer.JCI Insight2023
36713582Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile.Front Oncol2023
36870293Cigarette Smoke Enhances the Malignant Phenotype of Esophageal Adenocarcinoma Cells by Disrupting a Repressive Regulatory Interaction Between miR-145 and LOXL2.Lab Invest2023
36754859CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma.J Pathol Clin Res2023
34534680Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers.J Thorac Oncol2022
35462085Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.J Thorac Oncol2022
36270982A TNFR1-UBCH10 axis drives lung squamous cell carcinoma dedifferentiation and metastasis through a cell-autonomous signaling loop.Cell Death Dis2022
35793869Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature.J Immunother Cancer2022
36119066Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials.Front Immunol2022
36860703Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis.Cancer Res Commun2022
34534680Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers.J Thorac Oncol2022
35793869Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature.J Immunother Cancer2022
35462085Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.J Thorac Oncol2022
36860703Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis.Cancer Res Commun2022
36270982A TNFR1-UBCH10 axis drives lung squamous cell carcinoma dedifferentiation and metastasis through a cell-autonomous signaling loop.Cell Death Dis2022
36119066Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials.Front Immunol2022
32927122UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.J Thorac Oncol2021
34050543Post-thoracotomy neuralgic amyotrophy in a patient with BAP1 tumor predisposition syndrome: Multimodality longitudinal follow-up.Muscle Nerve2021
33996251MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis.Mol Ther Nucleic Acids2021
32927122UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.J Thorac Oncol2021
32580902Commentary: Keeping the target painted for precision cancer therapy.J Thorac Cardiovasc Surg2021
32770824Adenoid cystic carcinoma of the salivary gland metastasizing to the pericardium and diaphragm: Report of a rare case.Diagn Cytopathol2021
34515662Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus.Endocr Relat Cancer2021
34401309Fatal autoimmune pneumonitis requiring bilobectomy and omental flap repair in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).Respir Med Case Rep2021
34790904Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial Cells.JTO Clin Res Rep2021
34433910Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice.Oncogene2021
34430349Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.Transl Lung Cancer Res2021
34586369Characterization of Outcomes by Surgical Management of Lung Neuroendocrine Tumors Associated With Cushing Syndrome.JAMA Netw Open2021
34790904Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial Cells.JTO Clin Res Rep2021
34586369Characterization of Outcomes by Surgical Management of Lung Neuroendocrine Tumors Associated With Cushing Syndrome.JAMA Netw Open2021
34433910Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice.Oncogene2021
34430349Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.Transl Lung Cancer Res2021
34401309Fatal autoimmune pneumonitis requiring bilobectomy and omental flap repair in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).Respir Med Case Rep2021
34515662Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus.Endocr Relat Cancer2021
34050543Post-thoracotomy neuralgic amyotrophy in a patient with BAP1 tumor predisposition syndrome: Multimodality longitudinal follow-up.Muscle Nerve2021
33996251MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis.Mol Ther Nucleic Acids2021
  • 1 - 50 of 368

Recommended Authors

Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 0
Siddhartha Devarakonda
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 2011
Number of shared co-authors 2
Yisong Wang
Lombardi Comprehensive Cancer Center, Georgetown University
Career Start Year 2010
Number of shared co-authors 13
Larissa A Pikor
Ottawa Hospital Research Institute
Career Start Year 2010
Number of shared co-authors 0
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 1
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 0
Wei Zhang
Montefiore Medical Center
Career Start Year 2008
Number of shared co-authors 2
Matthew J Cecchini
Western University
Career Start Year 2008
Number of shared co-authors 0
John T Poirier
Laura and Isaac Perlmutter Cancer Center
Career Start Year 2007
Number of shared co-authors 4
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Ming Li
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 0
Kristopher K Frese
Cancer Research UK Manchester Institute, University of Manchester
Career Start Year 2003
Number of shared co-authors 1
Kostyantyn Krysan
David Geffen School of Medicine at University of California at Los Angeles
Career Start Year 1999
Number of shared co-authors 0
Collin M Blakely
University of California san francisco
Career Start Year 1998
Number of shared co-authors 0
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 1
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 0
Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1993
Number of shared co-authors 7
David N Watkins
Research Institute in Oncology and Hematology
Career Start Year 1991
Number of shared co-authors 0
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 5
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 8
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 3
Steven M Dubinett
David Geffen School of Medicine at university of california los angeles
Career Start Year 1987
Number of shared co-authors 1
Roy S Herbst
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 4
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 8
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 0
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 4
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 5
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 6
John D Minna
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1967
Number of shared co-authors 8

Collaborators

Julie A Hong
National Cancer Institute, National Institutes of Health
Co-authored papers 32
Sichuan Xi
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 17
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Co-authored papers 17
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 17
Mary Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 17
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Co-authored papers 16
Markku Miettinen
National Cancer Institute
Co-authored papers 11
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 10
Emily S Reardon
Center for Cancer Research National Cancer Institute, National Institutes of Health
Co-authored papers 7
Arun Rajan
Center for Cancer Research, National Cancer Institute
Co-authored papers 7
Jonathan C Nesbitt
Vanderbilt University Medical Center
Co-authored papers 7
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 6
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers 6
Nasser K Altorki
New York-Presbyterian Hospital
Co-authored papers 6
Giuseppe Giaccone
Meyer Cancer Center
Co-authored papers 6
Yuwei Zhang
Thoracic and GI Oncology Branch National Cancer Institute
Co-authored papers 5
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Itzhak Avital
Goldman School of Medicine, Ben Gurion University
Co-authored papers 5
Shaojian Gao
Co-authored papers 5
Fang Liu
Chengdu Military General Hospital
Co-authored papers 5
Vivek Shukla
Chalmers University of Technology
Co-authored papers 5
Aris Baras
Co-authored papers 5
Zied Abdullaev
Co-authored papers 4
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 4
Ronald M Summers
National Institutes of Health (NIH) Clinical Center
Co-authored papers 4
Maocheng Yang
College of Basic Medicine, Army Medical University
Co-authored papers 4
Patricia Fetsch
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Raphael Bueno
Co-authored papers 4
William Marston Linehan
Co-authored papers 4
Sandra Burkett
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Release 1.2